Literature DB >> 3989471

Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum.

F Alvarez, O Bernard, J C Homberg, G Kreibich.   

Abstract

Children with autoimmune chronic active hepatitis may have high titers of antibodies detected by immunofluorescence staining of hepatocytes and tubular cells in rat liver and kidney sections, respectively. These antibodies are directed against antigens contained in microsomal fractions prepared from these two organs. We have found that sera from these patients recognized a 50,000 mol wt protein present in higher concentration in smooth microsome subfractions compared with rough microsome subfractions. This protein is an integral membrane protein and is not glycosylated. It is exposed on the cytoplasmic face of the endoplasmic reticulum and is rather resistant to proteolysis with proteinase K. Since patients with liver disease of different etiology and similar severity of cell lysis do not give rise to liver-kidney microsome antibody (LKMA), lysis of hepatocytes is apparently not a sufficient condition for their development.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989471      PMCID: PMC2187601          DOI: 10.1084/jem.161.5.1231

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Release of poly A(+) messenger RNA from rat liver rough microsomes upon disassembly of bound polysomes.

Authors:  J Kruppa; D D Sabatini
Journal:  J Cell Biol       Date:  1977-08       Impact factor: 10.539

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Characterization of the microsomal antigen related to a subclass of active chronic hepatitis.

Authors:  M Rizzetto; F B Bianchi; D Doniach
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

4.  A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.

Authors:  J C Homberg; C Andre; N Abuaf
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

5.  Hepatocyte--collagen adhesion.

Authors:  B Obrink
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

6.  HBsAg-induced hypertrophic smooth endoplasmic reticulum as a target for liver-kidney microsomal (LKM) antibodies.

Authors:  G Ballardini; P Landi; C A Busachi; F B Bianchi; E Pisi
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

7.  Seroimmunologic classification of chronic hepatitis in 57 children.

Authors:  M Odièvre; G Maggiore; J C Homberg; F Saadoun; A M Couroucé; J Yvart; M Hadchouel; D Alagille
Journal:  Hepatology       Date:  1983 May-Jun       Impact factor: 17.425

8.  Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent.

Authors:  O Crivelli; C Lavarini; E Chiaberge; A Amoroso; P Farci; F Negro; M Rizzetto
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

9.  Selective release of content from microsomal vesicles without membrane disassembly. I. Permeability changes induced by low detergent concentrations.

Authors:  G Kreibich; P Debey; D D Sabatini
Journal:  J Cell Biol       Date:  1973-08       Impact factor: 10.539

10.  Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum.

Authors:  Y Fujiki; A L Hubbard; S Fowler; P B Lazarow
Journal:  J Cell Biol       Date:  1982-04       Impact factor: 10.539

View more
  26 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

Review 3.  Autoantibodies in primary biliary cirrhosis.

Authors:  P A Berg; R Klein
Journal:  Springer Semin Immunopathol       Date:  1990

4.  Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.

Authors:  R Klein; U M Zanger; T Berg; U Hopf; P A Berg
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

5.  A new antigen recognized by anti-liver-kidney-microsome antibody (LKMA).

Authors:  P Codońer-Franch; K Paradis; M Gueguen; O Bernard; A A Costesec; F Alvarez
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

6.  Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes.

Authors:  A M Yamamoto; C Mura; C De Lemos-Chiarandini; R Krishnamoorthy; F Alvarez
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

7.  Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.

Authors:  Y Ma; M Peakman; A Lobo-Yeo; L Wen; M Lenzi; J Gäken; F Farzaneh; G Mieli-Vergani; F B Bianchi; D Vergani
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.

Authors:  L Muratori; M Lenzi; Y Ma; M Cataleta; G Mieli-Vergani; D Vergani; F B Bianchi
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

9.  Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

Authors:  U M Zanger; H P Hauri; J Loeper; J C Homberg; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Argininosuccinate lyase: a new autoantigen in liver disease.

Authors:  N Pelli; A H Fensom; C Slade; F Boa; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.